Thrombosis and inflammatory bowel disease

被引:118
作者
Irving, PM
Pasi, KJ
Rampton, DS [1 ]
机构
[1] Barts & London Queen Marys Sch Med & Dent, Barts & London NHS Trust, Ctr Gastroenterol, Dept Gastroenterol, London E1 1BB, England
[2] Barts & London Queen Marys Sch Med & Dent, Barts & London NHS Trust, Ctr Haematol, Inst Cell & Mol Sci, London E1 1BB, England
关键词
D O I
10.1016/S1542-3565(05)00154-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Interaction between thrombosis and inflammation is increasingly recognized, With this, interest has arisen in the role of thrombosis in inflammatory conditions, including the inflammatory bowel diseases. Although the association between active inflammatory bowel disease and thromboembolic complications has long been known, there has been a resurgence in research into the role of thrombosis and the hemostatic system in the pathogenesis of both ulcerative colitis and Crohn's disease. Here we review the increased frequency of thromboembolic complications occurring in patients with inflammatory bowel disease; whether thrombosis might play a part in the initiation and maintenance of inflammation in inflammatory bowel disease; abnormalities of the coagulation system found in patients with inflammatory bowel disease; platelet dysfunction in inflammatory bowel disease; the mechanisms by which hemostatic processes might be proinflammatory in inflammatory bowel disease; and how these interactions might impact not only on the prevention of complications, but also on the treatment of the underlying inflammation in inflammatory bowel disease.
引用
收藏
页码:617 / 628
页数:12
相关论文
共 154 条
[1]   FREE PROTEIN-S DEFICIENCY IN PATIENTS WITH CHRONIC INFLAMMATORY BOWEL-DISEASE [J].
AADLAND, E ;
ODEGAARD, OR ;
ROSETH, A ;
TRY, K .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1992, 27 (11) :957-960
[2]  
Amirkhosravi A, 1996, THROMB HAEMOSTASIS, V75, P87
[3]   CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism [J].
André, P ;
Prasad, KSS ;
Denis, CV ;
He, M ;
Papalia, JM ;
Hynes, RO ;
Phillips, DR ;
Wagner, DD .
NATURE MEDICINE, 2002, 8 (03) :247-252
[4]   Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease [J].
Ang, YS ;
Mahmud, N ;
White, B ;
Byrne, M ;
Kelly, A ;
Lawler, M ;
McDonald, GSA ;
Smith, OP ;
Keeling, PWN .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (08) :1015-1022
[5]   Extensive arterial and venous thrombosis complicating chronic ulcerative colitis [J].
Bargen, JA ;
Barker, NW .
ARCHIVES OF INTERNAL MEDICINE, 1936, 58 (01) :17-31
[6]  
Beller F K, 1985, Obstet Gynecol Surv, V40, P425, DOI 10.1097/00006254-198507000-00003
[7]  
Bernstein CN, 2001, THROMB HAEMOSTASIS, V85, P430
[8]   SIDE-EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON THE SMALL AND LARGE-INTESTINE IN HUMANS [J].
BJARNASON, I ;
HAYLLAR, J ;
MACPHERSON, AJ ;
RUSSELL, AS .
GASTROENTEROLOGY, 1993, 104 (06) :1832-1847
[9]   Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis [J].
Bloom, S ;
Kiilerich, S ;
Lassen, MR ;
Forbes, A ;
Leiper, K ;
Langholz, E ;
Irvine, EJ ;
O'Morain, C ;
Lowson, D ;
Orm, S .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (08) :871-878
[10]   Elevated sevum levels and reduced immunohistochemical expression of thrombomodulin in active ulcerative colitis [J].
Boehme, MWJ ;
Autschbach, F ;
Zuna, I ;
Scherbaum, WA ;
Stange, E ;
Raeth, U ;
Sieg, A ;
Stremmel, W .
GASTROENTEROLOGY, 1997, 113 (01) :107-117